サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1526210

自動化された迅速微生物検査の世界市場

Automated and Rapid Microbiological Tests

出版日
ページ情報
英文 489 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.69円
自動化された迅速微生物検査の世界市場
出版日: 2024年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 489 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自動化された迅速微生物検査の世界市場は2030年までに100億米ドルに達する見込み

2023年に63億米ドルと推定される自動化された迅速微生物検査の世界市場は、分析期間2023-2030年にCAGR 6.7%で成長し、2030年には100億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるGC/CRT（臨床）アプリケーションは、CAGR 8.0％を記録し、分析期間終了までに13億米ドルに達すると予測されます。AISS（臨床）アプリケーション分野の成長率は、分析期間中CAGR 3.8％と推定されます。

米国市場は24億米ドルと推定、中国はCAGR9.3％で成長予測

米国の自動化された迅速微生物検査市場は2023年に24億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに10億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは9.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.0％と6.2％と予測されています。欧州では、ドイツがCAGR 5.5%で成長すると予測されています。

世界の自動化された迅速微生物検査市場- 主要動向と促進要因まとめ

自動化された迅速微生物検査は微生物学の分野で大きな進歩を遂げ、従来の方法と比較してより迅速で正確な微生物の検出を可能にしました。これらの検査は、分子生物学、免疫学、生化学などの先端技術を活用して、細菌、ウイルス、真菌、その他の病原体を同定します。自動化システムは、ロボット工学と洗練されたソフトウェアを統合し、サンプルの取り扱い、アッセイの実施、結果の解釈を最小限の人的介入で行い、微生物学的分析に必要な時間を数日から数時間、あるいは数分にまで大幅に短縮します。迅速な微生物学的検査は、臨床診断、医薬品製造、食品・飲食品の安全性、環境モニタリングなど、様々なアプリケーションにおいて極めて重要であり、そこでは病原体をタイムリーかつ正確に同定することが、健康と安全基準の維持に不可欠です。

技術の進歩は、自動化された迅速微生物検査の能力を高める上で極めて重要です。ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、質量分析における革新は、微生物検出の感度、特異性、速度を大幅に向上させました。さらに、POC（ポイント・オブ・ケア）検査機器や携帯型診断ツールの開発により、現場での検査が容易になり、病院、発生地域、生産施設などの重要な環境において即座の意思決定が可能になった。人工知能（AI）と機械学習（ML）アルゴリズムのこれらのシステムへの統合は、データ分析をさらに最適化し、リアルタイムのモニタリングと予測分析を可能にしました。このような技術的向上により、迅速微生物検査の有用性と利用しやすさが拡大し、現代の微生物学にとって不可欠なツールとなっています。

自動化された迅速微生物検査市場の成長は、いくつかの要因によって牽引されています。感染症の流行が増加し、迅速で正確な診断の必要性が高まっているため、迅速検査ソリューションの需要が大幅に増加しています。ヘルスケア分野では、院内感染を減らし、患者の予後を改善することが重視されているため、自動微生物検査システムが広く採用されています。製薬業界やバイオテクノロジー業界も、厳しい規制要件に後押しされ、製品の無菌性と品質を確保するためにこれらの検査に大きく依存しています。さらに、飲食品業界は、安全性と衛生基準の遵守を確保するために迅速微生物検査を利用しています。装置の小型化やユーザーフレンドリーなインターフェースの開発などの技術的進歩により、これらの検査はより幅広いユーザーにとって利用しやすくなっています。公衆衛生のインフラと対応能力の向上を目指した政府の取り組みと資金援助は、市場の成長をさらに後押ししています。これらの要因が、診断技術における継続的なイノベーションと相まって、自動化された迅速微生物検査市場の拡大を後押ししています。

調査対象企業の例（全77件）

  • 3M Company
  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Abbott Molecular, Inc.
  • American Type Culture Collection（ATCC）
  • Biocartis NV
  • Biomerica, Inc.
  • AutoGenomics, Inc.
  • BioControl Systems, Inc.
  • BioFire Diagnostics LLC
  • BIT Analytical Instruments GmbH
  • Biosystems S.A.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-1093

Global Automated and Rapid Microbiological Tests Market to Reach US$10.0 Billion by 2030

The global market for Automated and Rapid Microbiological Tests estimated at US$6.3 Billion in the year 2023, is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. GC/CRT (Clinical) Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the AISS (Clinical) Application segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 9.3% CAGR

The Automated and Rapid Microbiological Tests market in the U.S. is estimated at US$2.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Automated and Rapid Microbiological Tests Market - Key Trends & Drivers Summarized

Automated and rapid microbiological tests represent a significant advancement in the field of microbiology, providing faster and more accurate detection of microorganisms compared to traditional methods. These tests leverage advanced technologies such as molecular biology, immunology, and biochemistry to identify bacteria, viruses, fungi, and other pathogens. Automated systems integrate robotics and sophisticated software to handle samples, perform assays, and interpret results with minimal human intervention, drastically reducing the time required for microbiological analysis from days to hours or even minutes. Rapid microbiological tests are crucial in various applications, including clinical diagnostics, pharmaceutical manufacturing, food and beverage safety, and environmental monitoring, where timely and precise identification of pathogens is essential for maintaining health and safety standards.

Technological advancements have been pivotal in enhancing the capabilities of automated and rapid microbiological tests. Innovations in polymerase chain reaction (PCR), next-generation sequencing (NGS), and mass spectrometry have significantly improved the sensitivity, specificity, and speed of microbial detection. Additionally, the development of point-of-care (POC) testing devices and portable diagnostic tools has facilitated on-site testing, enabling immediate decision-making in critical settings such as hospitals, outbreak areas, and production facilities. The integration of artificial intelligence (AI) and machine learning (ML) algorithms into these systems has further optimized data analysis, allowing for real-time monitoring and predictive analytics. These technological improvements have expanded the utility and accessibility of rapid microbiological tests, making them indispensable tools in modern microbiology.

The growth in the automated and rapid microbiological tests market is driven by several factors. The rising prevalence of infectious diseases and the growing need for prompt and accurate diagnostics have significantly increased the demand for rapid testing solutions. In the healthcare sector, the emphasis on reducing hospital-acquired infections and improving patient outcomes has led to the widespread adoption of automated microbiological testing systems. The pharmaceutical and biotechnology industries also rely heavily on these tests for ensuring the sterility and quality of products, driven by stringent regulatory requirements. Additionally, the food and beverage industry uses rapid microbiological tests to ensure safety and compliance with health standards. Technological advancements, such as the miniaturization of devices and the development of user-friendly interfaces, have made these tests more accessible to a broader range of users. Government initiatives and funding aimed at improving public health infrastructure and response capabilities further support market growth. These factors, combined with continuous innovations in diagnostic technologies, are propelling the expansion of the automated and rapid microbiological tests market.

Select Competitors (Total 77 Featured) -

  • 3M Company
  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Abbott Molecular, Inc.
  • American Type Culture Collection (ATCC)
  • Biocartis NV
  • Biomerica, Inc.
  • AutoGenomics, Inc.
  • BioControl Systems, Inc.
  • BioFire Diagnostics LLC
  • BIT Analytical Instruments GmbH
  • Biosystems S.A.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Automated and Rapid Microbiological Tests: An Introduction
    • Enabling Technologies of Automated & Rapid Microbiological Tests
    • Clinical Applications of Automated & Rapid Microbiological Tests
    • Applications in Non-Clinical Investigations
    • Global Market Prospects & Outlook
    • Evolutionary Battle against Microbes Drives Market Future
    • Clinical Applications Lead the Global Market for Automated and Rapid Microbiological Testing
    • Developed Regions Lead, Developing Economies to Boost Future Growth
    • Competition
    • Recent Market Activity
    • Automated and Rapid Microbiological Tests - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Diagnostics Bring in a Transformation to Clinical Testing Practices
    • Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
    • Lab Automation Trend Augurs Well for Microbiological Testing Labs
    • Traditional Approaches Give Way to Modern Automated Microbiology Systems
    • Microbiology Laboratories Switch to Automation to Push Yields
    • Growing Incidence of Infectious Diseases to Fuel Demand for Rapid Microbiology Testing
    • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Rising Prevalence of Respiratory Infections Drive Market Growth
    • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
    • Rise in Prevalence of COPD Augments Demand
    • Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
    • Influenza Boosts Rapid Test Prospects
    • Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Opportunities for Automated Microbiology Tests
    • Percentage Share Breakdown of Global Deaths Linked to Air Pollution
    • Most Polluted Countries Worldwide: Average PM2.5 concentration (μg/m3)
    • Sustained Threat of HIV and Sexually Transmitted Diseases Amplify Need for Rapid Microbiological Testing
    • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region
    • Number of AIDS-Related Deaths (in Thousands) by Region
    • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
    • Home HIV Testing Emerges as a Lucrative Option
    • Advancements in Molecular Diagnostics Drive Market Growth
    • Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis
    • Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
    • Advancements in Molecular Diagnostics: A Boon for Rapid Microbiological Testing Market
    • Biotechnology: A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests
    • Healthcare Needs of the World's Aging Population: Potential Opportunity in Store
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Increase in Healthcare Spending in Emerging Markets to Propel Demand for Automated Microbiological Testing
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050
    • Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
    • Integration of Clinical Microbiology with Cloud Computing
    • Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
    • Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential...
    • Technological Advancements to Drive the Automated Microbiology Testing Market
    • Focus on Safe and High-Quality Foods Propels Rapid Microbiological Testing
    • Stringent Norms Necessitate Food Safety Testing
    • Food Microbiology Testing Market on a Growth Spree
    • Global Food Safety Testing Market Breakdown (in %) by Segment
    • Rapid and Automated Tests Emerge as an Attractive Solution
    • Leading Food Processors Exhibit Inclination Towards Rapid Microbiological Testing
    • Automation of Food Microbiology Labs
    • Poultry Industry Embraces Rapid Microbiological Testing Technologies
    • Rapid Microbial Testing in Dairy Industry
    • Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing
    • Technical and Cost Related Hurdles Hamper the Microbiology Testing Market
    • Rapid Microbiological Testing Gains Significance in the Pharmaceutical Industry
    • Key Advantages of Rapid Microbiological Tests for Pharmaceutical Industry
    • Growing Importance of Rapid Microbiological Testing for Pharma Laboratories
    • Key RMM Technologies for Pharmaceutical Industry
    • Adoption of Rapid Methods for QC Microbiology in Biopharmaceuticals
    • Advancements in Rapid Microbiological Testing for Pharmaceutical Industry
    • Rapid Microbial Testing for Regenerative Medicine: An Emerging Space
    • Rapid Microbiological Methods and the Regulatory Environment in Drug Development Industry
    • FDA's Requirements for Validation of RMM
    • EMA's Guidance on Use of RMMs for Water Testing
    • Rapid Microbial Testing Emerges as an Important Means for Quality Control of Advanced Therapies
    • Antibiotic Resistant Bacteria Throws the Spotlight on Rapid Microbial Testing Tools
    • Antimicrobial Vulnerability Testing and Identification of Microbial strains
    • Role of Microscopy in Antimicrobial Susceptibility Testing
    • Rising Prominence of NAAT-Driven AST
    • Economic Factors Promise Growth for Rapid AST
    • Rapid Technologies Gain Momentum in Environment Testing Field
    • Deteriorating Quality of Water Throws Emphasis on Water Testing Services
    • Percentage of Contaminated Water in Drinking Water Supplies in Africa, Asia, and Latin America and Caribbean
    • Key Issues Confronting the Rapid Microbiological Tests Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for GC/CRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for AISS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for ABCS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for SIRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for ATS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Applications (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Non-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Automated and Rapid Microbiological Tests Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Rising Threat of Infectious Diseases Drive Significance of Rapid Microbiological Testing
    • Unmet Diagnostic Needs of Aging Population: Major Driver
    • US Elderly Population: Expected Growth Rates Over the Years 2005-2025
    • North American Aging Population by Age Group: 1975-2050
    • Select Product Categories in Rapid Microbiological Testing - An Overview
    • Automated Susceptibility Testing Systems
    • STD Rapid Tests
    • Respiratory Rapid Tests
    • Streptococcus Infection Rapid Tests
    • Food Safety Microbiological Testing Market: Concerns over Food Safety Drive Market Gains
    • Foodborne Illnesses, Hospitalizations and Deaths in the US: Percentage Breakdown for Known Pathogens and Unspecified Agents
    • Leading Pathogens Causing Foodborne Illnesses in the US: Percentage Breakdown of Number of Illnesses by Known Pathogens
    • TABLE 26: USA Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • JAPAN
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Market Overview
    • Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • CHINA
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Market Overview
    • TABLE 35: China Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • EUROPE
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • Growth in Clinical Diagnostics Automation
    • Rise in Automated and Rapid Tests in Clinical Applications
    • Aging Demography: An Opportunity Indicator
    • Food Safety Testing Market in Europe: An Overview
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • FRANCE
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: France 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • GERMANY
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 47: Germany Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Germany Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Germany 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Italy 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 53: UK Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: UK Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: UK 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 56: Spain Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Spain Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Spain 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 59: Russia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Russia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Russia 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Rest of Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • Market Overview
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 71: Australia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Australia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Australia 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • INDIA
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • Market Overview
    • Demand for Automated and Rapid Microbiology Testing Poised for Growth
    • Automation - Name of the Game
    • Private Enterprises Encourage Changes in Diagnostics Sector
    • TABLE 74: India Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: India Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: India 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 77: South Korea Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: South Korea Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: South Korea 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Latin America 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 86: Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Latin America 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 89: Argentina Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Argentina Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Argentina 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 92: Brazil Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Brazil Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Brazil 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 95: Mexico Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Mexico Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Mexico 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 98: Rest of Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Latin America 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Middle East 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 104: Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Middle East 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 107: Iran Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Iran Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Iran 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 110: Israel Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Israel Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Israel 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 113: Saudi Arabia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Saudi Arabia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Saudi Arabia 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 116: UAE Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UAE Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UAE 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 119: Rest of Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Middle East 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
  • AFRICA
    • Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 122: Africa Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Africa Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Africa 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030

IV. COMPETITION